» Articles » PMID: 34267816

LncRNA LOXL1-AS1 Promotes Liver Cancer Cell Proliferation and Migration by Regulating the MiR-377-3p/NFIB Axis

Overview
Journal Oncol Lett
Specialty Oncology
Date 2021 Jul 16
PMID 34267816
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Liver cancer is becoming one of the most lethal malignancies due to its high incidence and mortality. Accumulating studies have indicated that long non-coding RNAs (lncRNAs) are critical regulators of the tumorigenesis and development of various types of cancer, including liver cancer. LncRNA LOXL1-antisense RNA 1 (LOXL1-AS1) has been identified as an oncogene in some types of human cancer; however, its role in liver cancer remains obscure. Reverse transcription-quantitative PCR was used to measure LOXL1-AS1 expression in liver cancer tissues and cells. Western blot, MTT, colony formation, glucose uptake and wound healing assays were used to explore the biological function of LOXL1-AS1 in liver cancer cells. Bioinformatics analysis and RNA pull-down and luciferase reporter assays were used to explore the molecular mechanism of LOXL1-AS1 in liver cancer cells. Statistical analysis was used to compare the experimental results of different groups. In the present study, LOXL1-AS1 expression was significantly upregulated in liver cancer tissues and cells compared with in normal liver tissues and cells, respectively. High LOXL1-AS1 expression was associated with poor clinical outcomes in patients with liver cancer. Furthermore, LOXL1-AS1-knockdown suppressed glucose metabolism, proliferation, migration and epithelial-mesenchymal transition (EMT) of liver cancer cells. Subsequently, LOXL1-AS1 acted as a microRNA (miR)-377-3p sponge, and nuclear factor I B (NFIB) was confirmed as the downstream target of miR-377-3p in liver cancer cells. Additionally, rescue assays suggested that NFIB overexpression countervailed the inhibitory influence of LOXL1-AS1 silencing on liver cancer cellular processes. The present study demonstrated that LOXL1-AS1 promoted glucose metabolism, proliferation, migration and EMT of liver cancer cells by sponging miR-377-3p and modulating NFIB, which may provide a novel insight for the treatment of liver cancer.

Citing Articles

Tristetraprolin Family Members and Processing Bodies: A Complex Regulatory Network Involved in Fatty Liver Disease, Viral Hepatitis and Hepatocellular Carcinoma.

Gellee N, Legrand N, Jouve M, Devaux P, Dubuquoy L, Sobolewski C Cancers (Basel). 2025; 17(3).

PMID: 39941720 PMC: 11815756. DOI: 10.3390/cancers17030348.


Icariin mediates autophagy and apoptosis of hepatocellular carcinoma cells induced by the β-catenin signaling pathway through lncRNA LOXL1-AS1.

Gao S, Zhang W, Dai J, Hu W, Xu Y, Yang H Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39812768 DOI: 10.1007/s00210-024-03692-6.


Effects of the lncRNA NBR2 on the proliferation and autophagy of breast cancer cells under starvation conditions.

Yang J, Gao L, Wang Z, Xu Y, Jin X, Jin Q Sci Rep. 2024; 14(1):22624.

PMID: 39349960 PMC: 11442952. DOI: 10.1038/s41598-024-72181-w.


A comprehensive review on lncRNA LOXL1-AS1: molecular mechanistic pathways of lncRNA LOXL1-AS1 in tumorigenicity of cancer cells.

Yousefnia S Front Oncol. 2024; 14:1384342.

PMID: 39136001 PMC: 11317273. DOI: 10.3389/fonc.2024.1384342.


Involvement of long non-coding RNA LOXL1-AS1 in the tumourigenesis and development of malignant tumours: a narrative review.

Wang X, Liu R, Li J, Wang B, Lin Y, Zi J Transl Cancer Res. 2024; 13(6):3142-3155.

PMID: 38988912 PMC: 11231786. DOI: 10.21037/tcr-23-2282.


References
1.
Liu Y, Guo C, Li F, Wu L . LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression. Cell Biochem Funct. 2019; 38(1):58-65. DOI: 10.1002/cbf.3449. View

2.
Li Z, Zhang H . Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression. Cell Mol Life Sci. 2015; 73(2):377-92. PMC: 11108301. DOI: 10.1007/s00018-015-2070-4. View

3.
Li W, Zhang B, Jia Y, Shi H, Wang H, Guo Q . LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2. Cancer Med. 2019; 9(2):689-699. PMC: 6970024. DOI: 10.1002/cam4.2641. View

4.
Ding L, Li Y, Wang S, Wang X, Fang F, Wang W . Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1. Int J Mol Sci. 2016; 17(10). PMC: 5085650. DOI: 10.3390/ijms17101617. View

5.
Zhang B, Zhou M, Zou L, Miao J, Wang Y, Li Y . Long non-coding RNA LOXL1-AS1 acts as a ceRNA for miR-324-3p to contribute to cholangiocarcinoma progression via modulation of ATP-binding cassette transporter A1. Biochem Biophys Res Commun. 2019; 513(4):827-833. DOI: 10.1016/j.bbrc.2019.04.089. View